FDA Webview
X

Free FDA Notices

FDA Renews Oncologic Drugs Panel

09/08/2016

Federal Register Notice: The FDA commissioner is renewing the charter of the Oncologic Drugs Advisory Committee for an additional two years beyond the charter expiration date. The new charter will be in effect until 9/1/18. To view this notice, click here.

LATEST NEWS